Archive for 'Regulators' Category

Pyrimethamine Poisoning in Pakistan

By Anthony - Last updated: Wednesday, February 8, 2012

The number of dead in the wake of the substandard medicines disaster in Pakistan continues to rise with approximately 140 patients killed. Another 50 are not expected to survive. The product involved was isosorbide mononitrate tablets, commonly used in heart failure and angina, which was provided free by the Punjab Institute for Cardiology to patients […]

Nazis, concentration camps, & thalidomide

By Anthony - Last updated: Thursday, November 3, 2011

In a piece on what ever happened to the thalidomide babies Frederick Dove raises the issue of a Nazi link to thalidomide (Contergan was its German trade name) . This is important because the victims of thalidomide may then be able to leverage greater support and help for survivors. It is worth noting that German […]

Xigris Grounded

By Anthony - Last updated: Tuesday, October 25, 2011

Drotrecogin alfa (Xigris) has been withdrawn from the market, because it doesn’t work. It was granted a licence in the full knowledge that insufficient data existed for a standard licence, and was under yearly review by the European Medicines Agency. It was restricted for use in those with severe sepsis and at least two organ […]

Magical cancer drug

By Anthony - Last updated: Tuesday, October 12, 2010

Any treatment that ameliorates cancer, never mind cure it, is good news. Unequivocally. However, sometimes you have to wonder at the way in which information about new cancer treatments hits the public. First a paper is presented at a conference. Abiraterone increases median survival in currently untreatable prostate cancer by four months: “This is a […]

Homeopathy and Pharmacy

By Anthony - Last updated: Monday, February 22, 2010

The House of Commons select committee on science and technology has been examining homeopathy, and their report has been just been released. The main focus will be on the committee’s view that both NHS funding and MHRA licencing should be withdrawn. I’ll focus on the parts related more directly to Pharmacy and the Royal Pharmaceutical […]

Short but effective

By Anthony - Last updated: Friday, June 26, 2009

Stephen J Evans, Professor of Pharmacoepidemiology, on the recent licensing of a homeopathy preparation in this weeks BMJ: It is tragic that we now have a respected body, the Medicines and Healthcare products Regulatory Agency (MHRA), granting a licence for a product for which there is not only no evidence of efficacy but good evidence […]

Homeopathic victory?

By Anthony - Last updated: Saturday, May 2, 2009

About three years ago there was considerable concern about the Medicines and Healthcare products Regulatory Agency (MHRA) becoming associated with homeopathy. The Medicines and Healthcare products Regulatory Agency (MHRA) is introducing rules to allow remedies to specify the ailments for which they can be used. But critics argue the treatments will not be rigorously tested […]

Chinese scapegoats

By Anthony - Last updated: Thursday, January 22, 2009

The Chinese government are executing two individuals in the melamine milk scandal. The contaminated milk killed six babies. Many people’s instinctive reaction might be to welcome this punishment, but the punishment deflects attention away from the failure of the Chinese authorities to properly regulate industry. As I have written here, the unregulated capitalism in China […]

Long-acting beta agonists in asthma under scrutiny

By Anthony - Last updated: Saturday, December 13, 2008

The Washington Post reports on an FDA decision on long-acting beta agonists (LABAs) in asthma: The risks of two widely used asthma drugs outweigh their benefits for both children and adults, a U.S. Food and Drug Administration advisory panel said Thursday. The health panel targeted GlaxoSmithKline’s Serevent [salmeterol] and Foradil [formoterol], made jointly by Novartis […]